digoxin and Disease

Topics: Adult; Aged; Aging; Aminopyrine; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antipyrine; Barbiturates; Blood Proteins; Digoxin; Disease; Female; Humans; Intestinal Absorption; Kidney; Kinetics; Male; Middle Aged; Pharmaceutical Preparations; Phenytoin; Protein Binding; Rats

The human hypothalamus synthesis an endogenous membrane Na(+)-K(+) ATPase inhibitor, digoxin. A digoxin-mediated model for quantal perception of geomagnetic fields is proposed. External geomagnetic fields can produce membrane Na(+)-K(+) ATPase inhibition. The inhibition of Na(+)-K(+) ATPase can contribute to increase in intracellular calcium and decrease in magnesium, which can result in (1) defective neurotransmitter transport mechanism, (2) neuronal degeneration and apoptosis, (3) mitochondrial dysfunction, (4) defective golgi body function and protein processing dysfunction, (5) immune dysfunction and oncogenesis. Geomagnetic fields can thus regulate cellular function and contributing to the pathogenesis of disease.

Topics: Apoptosis; Digoxin; Disease; Electromagnetic Fields; Golgi Apparatus; Humans; Hypothalamus; Immune System; Mitochondria; Neurons; Neurotransmitter Agents; Sodium-Potassium-Exchanging ATPase

A family with a high prevalence of Parkinson's disease, schizophrenia, neoplasms, syndrome-X, rheumatoid arthritis and epilepsy has been described. The psychological behavioural patterns of the family were as follows--creativity and high IQ, hypersexual behaviour, reduced appetite and eating behaviour, insomnia and reduced sleep patterns, increased tendency for spirituality, increased tendency for addiction, less of bonding and affectionate behaviour and left handedness. Digoxin, an endogenous Na(+)-K(+) ATPase inhibitor secreted by the hypothalamus, was found to be elevated and RBC membrane Na(+)-K(+) ATPase activity was found to be reduced in all the disorders and in the indexed family studied. Hypothalamic digoxin can modulate conscious perception and its dysfunction may lead to schizophrenia. Digoxin can also preferentially upregulate tryptophan transport over tyrosine resulting in increased levels of depolarising tryptophan catabolites - serotonin, quinolinic acid, strychnine and nicotine and decreased levels of hyperpolarising tyrosine catabolites dopamine, noradrenaline and morphine contributing to membrane Na(+)-K(+) ATPase inhibition in all the above disorders and the indexed family. Digoxin induced membrane Na(+)-K(+) ATPase inhibition can result in increased intracellular Ca(2+) and reduced Mg(++) levels leading to glutamate excitotoxicity, oncogene activation and immune activation. Digoxin induced altered Ca(++)/Mg(++) ratios, reduced ubiquinone and increased dolichol can affect glycoconjugate metabolism, membrane formation and structure and mitochondrial function leading to the diverse disorders described above including those in the indexed family. The isoprenoid pathway and neurotransmitter patterns were compared in right-handed/left hemispheric dominant and left-handed/right hemispheric dominant individuals. The biochemical patterns in the indexed family and the diverse disorders studied correlated with those obtained in right hemispheric dominance. The hyperdigoxinemic state indicates right hemispheric dominance. Hypothalamic digoxin can thus function as the master conductor of the neuroimmunoendocrine orchestra and co-ordinate the functions of various cellular organelles.

Topics: Digoxin; Disease; Family Health; Female; Free Radicals; Functional Laterality; Humans; Hypothalamus; Lysosomes; Male; Mental Disorders; Neurons; Pedigree; Sodium-Potassium-Exchanging ATPase; Tryptophan; Tyrosine

Topics: Adolescent; Adult; Child; Child, Preschool; Digoxin; Disease; Drug Administration Schedule; Humans; Infant; Lidocaine; Penicillin G; Procainamide; Theophylline

All drugs are not created equal even if the pharmacopoeia seems to suggest they are. Factors that affect bioavailability among drugs of the same type (especially oral drugs) include not only disintegration and absorption rates but also the amount of food taken before or with the dose, interactions with other drugs, the physical state of the patient, and the "first-pass effect" upon drug with high liver clearance.

Topics: Age Factors; Biological Availability; Biopharmaceutics; Biotransformation; Digoxin; Disease; Dosage Forms; Drug Administration Schedule; Drug Interactions; Ethanol; Food; Gastric Mucosa; Humans; Intestinal Absorption; Liver; Prednisolone; Prednisone; Solutions; Time Factors